Dr Sanmarié Schlebusch

Accreditation

• Hospitals MPHB MPHR MAH MCPH MCH MMPH MMH
• Speciality Pathology
• InterestsDr Schlebusch specialises in general microbiology but particularly molecular microbiology and other modern technologies for the identification of infectious agents e.g. MALDI-TOF and PCR.

Biography

Dr Sanmarié Schlebusch obtained her MBChB from the University of Pretoria in South Africa. After moving to Australia in 2002 she initially worked as a general practitioner before specialising in microbiology and obtaining her FRCPA in 2009. She has worked in both private and public pathology before joining Mater Pathology in 2010.

Dr Schlebusch has a keen interest in modern technologies for diagnosis of infectious diseases and antimicrobial resistance. She has performed research on staphylococcal toxic shock and developed a PCR to detect the toxic shock gene in S. aureus and she has been the first microbiologist in Queensland to publish on the use of MALDI-TOF-MS. MALDI-TOF-MS (matrix assisted laser desorption/ionisation time-of-flight mass spectrometry) is a new technology which can identify micro-organisms within minutes and is currently being introduced at Mater Pathology.

Dr Schlebusch has published on application and utility of MALDI-TOF MS for rapid identification of multiresistant gram-negative organisms such as Burkholderia cepacia from patients with cystic fibrosis in the Australian diagnostic microbiology laboratory, with the Australian Society for Antimicrobials for their annual conference in February 2011.

View other publications by Dr Sanmarié Schlebusch.